Life Changing Outcomes
DatChem-Breast
Defining DatChem-Breast
- DatChem-Breast is performed on women already booked for a breast MRI.
- It adds 15 minutes to the MRI examination.
- The chemical data is sent from the MRI for evaluation.
- The report is returned to the MRI console and available for the reporting radiologist.
DatChem-Breast identifies signs of cancer up to to five years before it can be seen by imaging.
The Biology of Breast Cancer Development
Cancer is a genetic disease. Development and growth that drives the development of a cancer many years before cancer appears.
- Once a cancer has started, it grows slowly
- Cellular chemistry changes with each stage of development
- Once it ceases to be normal, DatChem-Breast calls the tissue Switched On
- When palpable, the tumor has been growing for 2 to 5 years.
Longitudinal Study of a High-Risk Patient with Dense Breast Tissue
DatChem-Breast identified severe chemical dysregulation in 2013, but the cancer was only diagnosed by MRI in June 2016.
November 2013
November 2014
April 2015
How DatChem-Breast works
DatChem-Breast assesses breast chemistry and identifies changes associated with a developing cancer before it can be seen by imaging
Provides a warning of dysregulation prior and:
- Reveals varying degrees of chemical dysregulation showing how far its lipids and other molecules have deviated from normal
- If the either of two tumor promoters (MMA or UDP) are present in the breast tissue.
See the Difference
Achieving Better Outcomes
Multiple DatChem-Breast scans will provide longitudinal risk assessment
After the first DatChem-Breast the patient is her own control
Breast cancer develops slowly over many years
Managed anxiety by revealing normal DatChem-Breast and use time and repeated testing